Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precise mapping of single-stranded DNA breaks by sequence-templated erroneous DNA polymerase end-labelling. | Nat Commun | 2025 | 40759655 | PubTator, text mining | PubMed |
| Unraveling the Role of Topoisomerase 3β (TOP3B) in mRNA Translation and Human Disease. | Wiley Interdiscip Rev RNA | 2025 | 40754336 | PubTator, text mining | PubMed |
| CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer. | Cell Death Dis | 2025 | 40750787 | PubTator, text mining | PubMed |
| Srs2 binding to proliferating cell nuclear antigen (PCNA) and its sumoylation contribute to replication protein A (RPA) antagonism during the DNA damage response. | Elife | 2025 | 40748045 | PubTator, text mining | PubMed |
| Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. | Orphanet J Rare Dis | 2025 | 40739565 | PubTator, text mining | PubMed |
| The association between circulating SIGLEC6 and preeclampsia: observational studies of seven cohorts. | EBioMedicine | 2025 | 40737757 | PubTator, text mining | PubMed |
| Participants in Transcription-Replication Conflict and Their Role in Formation and Resolution of R-Loops. | Int J Mol Sci | 2025 | 40725198 | PubTator, text mining | PubMed |
| Heterogeneity-Aware Personalized Federated Neural Architecture Search. | Entropy (Basel) | 2025 | 40724475 | PubTator, text mining | PubMed |
| Transcription-coupled repair of crosslinking DNA damage. | DNA Repair (Amst) | 2025 | 40706399 | PubTator, text mining | PubMed |
| Synthesis and investigation of thieno[2,3-b]pyridines that restore activity of topotecan. | RSC Med Chem | 2025 | 40689026 | PubTator, text mining | PubMed |
| Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments. | Expert Opin Investig Drugs | 2025 | 40682348 | PubTator, text mining | PubMed |
| TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile. | Mol Cancer Ther | 2025 | 40667801 | PubTator, text mining | PubMed |
| Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation. | Int J Mol Sci | 2025 | 40649791 | PubTator, text mining | PubMed |
| Utilizing TOP2 Class for Hybrid Decision-Making to Enhance TOP1 Accuracy of Ensemble Models. | IEEE Trans Neural Netw Learn Syst | 2025 | 40608870 | PubTator, text mining | PubMed |
| Joint fusion of sequences and structures of drugs and targets for identifying targets based on intra and inter cross-attention mechanisms. | BMC Biol | 2025 | 40598296 | PubTator, text mining | PubMed |
| Diagnostic Performance of ChatGPT-4o and DeepSeek-3 Differential Diagnosis of Complex Oral Lesions: A Multimodal Imaging and Case Difficulty Analysis. | Oral Dis | 2025 | 40589366 | PubTator, text mining | PubMed |
| Setting new benchmarks in AI-driven infrared structure elucidation. | Digit Discov | 2025 | 40585278 | PubTator, text mining | PubMed |
| An efficient parallel DCNN algorithm in big data environment. | PeerJ Comput Sci | 2025 | 40567681 | PubTator, text mining | PubMed |
| LncRNA-Protein Interactions: A Key to Deciphering LncRNA Mechanisms. | Biomolecules | 2025 | 40563521 | PubTator, text mining | PubMed |
| Topoisomerase I Inhibition in ETV4-overexpressed Non-Small Cell Lung Cancer Promotes Replication and Transcription Mediated R-Loop Accumulation and DNA Damage. | Adv Sci (Weinh) | 2025 | 40548893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=11